Search | SGO ConnectEd

PARP Inhibitor Maintenance Therapy after Initial Chemotherapy for Advanced Ovary, Fallopian Tube and Primary Peritoneal Cancers
Keeping up with the Chemos Series: Tisotumab Vedotin - Preparing to Give It (Part 1)
Keeping up with the Chemos Series: Tisotumab Vedotin - Administration (Part 2)
Keeping up with the Chemos Series: Tisotumab Vedotin - Follow up Monitoring Between Cycles (Part 3)
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Preparing to Give It (Part 1)
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Administration (Part 2)
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Follow up Monitoring Between Cycles (Part 3)
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Preparing to Give It (Part 1)
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Administration (Part 2)
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Follow up Monitoring Between Cycles (Part 3)
Keeping up with the Chemos Series: Trametinib - Preparing to Give It (Part 1)
Keeping Up with the Chemos: Trabectedin and Doxorubicin - Preparing to Give It (Part 1)
Keeping Up with the Chemos: Trabectedin and Doxorubicin - Administration (Part 2)
Keeping Up with the Chemos: CDK4/6 Inhibitors - Preparing to Give It (Part 1)
Keeping Up With the Chemos: CDK4/6 Inhibitors - Administration (Part 2)
SGO Oncofertility Part 2: Risks of Premature Ovarian Failure